Gerresheimer AG
F:GXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gerresheimer AG
F:GXI
|
DE |
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
Wall St Price Targets
GXI Price Targets Summary
Gerresheimer AG
According to Wall Street analysts, the average 1-year price target for GXI is 32.98 EUR with a low forecast of 12.79 EUR and a high forecast of 106.41 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GXI's stock price target?
Price Target
32.98
EUR
According to Wall Street analysts, the average 1-year price target for GXI is 32.98 EUR with a low forecast of 12.79 EUR and a high forecast of 106.41 EUR.
What is the Revenue forecast for Gerresheimer AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Gerresheimer AG?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for Gerresheimer AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 5 years is 12%.
